No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs75065324 |
chr11:48074401-48074402 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs187355101 |
chr11:48074442-48074443 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs538209524 |
chr11:48074456-48074457 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs138070886 |
chr11:48074457-48074458 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs142298817 |
chr11:48074465-48074466 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs536200981 |
chr11:48074530-48074531 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs553116462 |
chr11:48074569-48074570 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs140889085 |
chr11:48074616-48074617 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs191908307 |
chr11:48074674-48074675 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs7113246 |
chr11:48074734-48074735 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs34549630 |
chr11:48074810-48074811 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs189041110 |
chr11:48074840-48074841 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs7113511 |
chr11:48074933-48074934 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs572712227 |
chr11:48074972-48074973 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs530658915 |
chr11:48075026-48075027 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs543755259 |
chr11:48075106-48075107 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs553237975 |
chr11:48075152-48075153 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs61470520 |
chr11:48075154-48075155 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs530408826 |
chr11:48075174-48075175 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs547014737 |
chr11:48075220-48075221 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs560716713 |
chr11:48075231-48075232 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs182139931 |
chr11:48075232-48075233 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs374608879 |
chr11:48075305-48075306 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs569333618 |
chr11:48075349-48075350 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs186698808 |
chr11:48075363-48075364 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs148203609 |
chr11:48075369-48075370 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs11290681 |
chr11:48075483-48075484 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs35795755 |
chr11:48075501-48075502 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs191571681 |
chr11:48075506-48075507 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs148569728 |
chr11:48075524-48075525 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs189839248 |
chr11:48075609-48075610 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs552962379 |
chr11:48075612-48075613 |
Weak transcription Enhancers Genic enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|